DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review

The prevalence of breast cancer in young women (YWBC) has increased alarmingly. Significant efforts are being made to elucidate the biological mechanisms concerning the development, prognosis, and pathological response in early-onset breast cancer (BC) patients. Dysfunctional DNA repair proteins are...

Full description

Bibliographic Details
Main Authors: Laura Keren Urbina-Jara, Emmanuel Martinez-Ledesma, Augusto Rojas-Martinez, Francisco Ricardo Rodriguez-Recio, Rocio Ortiz-Lopez
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/23/13030
_version_ 1797507701433958400
author Laura Keren Urbina-Jara
Emmanuel Martinez-Ledesma
Augusto Rojas-Martinez
Francisco Ricardo Rodriguez-Recio
Rocio Ortiz-Lopez
author_facet Laura Keren Urbina-Jara
Emmanuel Martinez-Ledesma
Augusto Rojas-Martinez
Francisco Ricardo Rodriguez-Recio
Rocio Ortiz-Lopez
author_sort Laura Keren Urbina-Jara
collection DOAJ
description The prevalence of breast cancer in young women (YWBC) has increased alarmingly. Significant efforts are being made to elucidate the biological mechanisms concerning the development, prognosis, and pathological response in early-onset breast cancer (BC) patients. Dysfunctional DNA repair proteins are implied in BC predisposition, progression, and therapy response, underscoring the need for further analyses on DNA repair genes. Public databases of large patient datasets such as METABRIC, TCGA, COSMIC, and cancer cell lines allow the identification of variants in DNA repair genes and possible precision drug candidates. This study aimed at identifying variants and drug candidates that may benefit Latin American (LA) YWBC. We analyzed pathogenic variants in 90 genes involved in DNA repair in public BC datasets from METABRIC, TCGA, COSMIC, CCLE, and COSMIC Cell Lines Project. Results showed that reported DNA repair germline variants in the LA dataset are underrepresented in large databases, in contrast to other populations. Additionally, only six gene repair variants in women under 50 years old from the study population were reported in BC cell lines. Therefore, there is a need for new approaches to study DNA repair variants reported in young women from LA.
first_indexed 2024-03-10T04:52:11Z
format Article
id doaj.art-4d5030874f434eb19ac4796119be8596
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:52:11Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4d5030874f434eb19ac4796119be85962023-11-23T02:32:03ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-0122231303010.3390/ijms222313030DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic ReviewLaura Keren Urbina-Jara0Emmanuel Martinez-Ledesma1Augusto Rojas-Martinez2Francisco Ricardo Rodriguez-Recio3Rocio Ortiz-Lopez4Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey 64710, MexicoTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey 64710, MexicoTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey 64710, MexicoTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey 64710, MexicoTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey 64710, MexicoThe prevalence of breast cancer in young women (YWBC) has increased alarmingly. Significant efforts are being made to elucidate the biological mechanisms concerning the development, prognosis, and pathological response in early-onset breast cancer (BC) patients. Dysfunctional DNA repair proteins are implied in BC predisposition, progression, and therapy response, underscoring the need for further analyses on DNA repair genes. Public databases of large patient datasets such as METABRIC, TCGA, COSMIC, and cancer cell lines allow the identification of variants in DNA repair genes and possible precision drug candidates. This study aimed at identifying variants and drug candidates that may benefit Latin American (LA) YWBC. We analyzed pathogenic variants in 90 genes involved in DNA repair in public BC datasets from METABRIC, TCGA, COSMIC, CCLE, and COSMIC Cell Lines Project. Results showed that reported DNA repair germline variants in the LA dataset are underrepresented in large databases, in contrast to other populations. Additionally, only six gene repair variants in women under 50 years old from the study population were reported in BC cell lines. Therefore, there is a need for new approaches to study DNA repair variants reported in young women from LA.https://www.mdpi.com/1422-0067/22/23/13030DNA repair genesbreast cancer in young womenbreast cancer datasetscell linestherapy
spellingShingle Laura Keren Urbina-Jara
Emmanuel Martinez-Ledesma
Augusto Rojas-Martinez
Francisco Ricardo Rodriguez-Recio
Rocio Ortiz-Lopez
DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review
International Journal of Molecular Sciences
DNA repair genes
breast cancer in young women
breast cancer datasets
cell lines
therapy
title DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review
title_full DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review
title_fullStr DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review
title_full_unstemmed DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review
title_short DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review
title_sort dna repair genes as drug candidates for early breast cancer onset in latin america a systematic review
topic DNA repair genes
breast cancer in young women
breast cancer datasets
cell lines
therapy
url https://www.mdpi.com/1422-0067/22/23/13030
work_keys_str_mv AT laurakerenurbinajara dnarepairgenesasdrugcandidatesforearlybreastcanceronsetinlatinamericaasystematicreview
AT emmanuelmartinezledesma dnarepairgenesasdrugcandidatesforearlybreastcanceronsetinlatinamericaasystematicreview
AT augustorojasmartinez dnarepairgenesasdrugcandidatesforearlybreastcanceronsetinlatinamericaasystematicreview
AT franciscoricardorodriguezrecio dnarepairgenesasdrugcandidatesforearlybreastcanceronsetinlatinamericaasystematicreview
AT rocioortizlopez dnarepairgenesasdrugcandidatesforearlybreastcanceronsetinlatinamericaasystematicreview